Posted On: 04/15/2015 5:07:44 PM
Post# of 63749
$CLSN Pr breakout gap $3.15
8:04 am Celsion announces positive interim data from its Phase 2 DIGNITY
study in breast cancer; ThermoDox continued to demonstrate positive local
response rate in highly refractory patientsBriefing.com(Wed 8:04AM EDT)
Website
Shares Outstanding: 19.98M
Float: 17.22M
% Held by Insiders: 26.34%
% Held by Institutions: 16.70%
Shares Short (as of Mar 31, 2015): 380.32K
Short Ratio (as of Mar 31, 2015): 4.50
Short % of Float (as of Mar 31, 2015): 2.20%
Shares Short (prior month): 379.65K
Headlines
8:04 am Celsion announces positive interim data from its Phase 2 DIGNITY
study in breast cancer; ThermoDox continued to demonstrate positive local
response rate in highly refractory patientsBriefing.com(Wed 8:04AM EDT)
Website
Shares Outstanding: 19.98M
Float: 17.22M
% Held by Insiders: 26.34%
% Held by Institutions: 16.70%
Shares Short (as of Mar 31, 2015): 380.32K
Short Ratio (as of Mar 31, 2015): 4.50
Short % of Float (as of Mar 31, 2015): 2.20%
Shares Short (prior month): 379.65K
Headlines
(0)
(0)Scroll down for more posts ▼
